Justice Abotsi

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

Richard Odame Phillips, J. Robert, Kabiru Mohamed Abass et al. · The Lancet · 2020 · 110 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Clinical and Bacteriological Efficacy of Rifampin-Streptomycin Combination for Two Weeks followed by Rifampin and Clarithromycin for Six Weeks for Treatment of Mycobacterium ulcerans Disease

Richard Odame Phillips, Fred Stephen Sarfo, Mohammed K. Abass et al. · Antimicrobial Agents and Chemotherapy · 2013 · 65 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease

Fred Stephen Sarfo, Richard Odame Phillips, Jihui Zhang et al. · BMC Infectious Diseases · 2014 · 62 citations · Full text

Medicine, Dermatology, Pharmacology +15

Buruli Ulcer Control in a Highly Endemic District in Ghana: Role of Community-Based Surveillance Volunteers

Kabiru Mohammed Abass, Tjip S. van der Werf, Richard Odame Phillips et al. · American Journal of Tropical Medicine and Hygiene · 2014 · 47 citations · Full text

Public Health, Community Health, Infectious Diseases +15

Infection with<i>Mansonella perstans</i>Nematodes in Buruli Ulcer Patients, Ghana

Richard Odame Phillips, Michael Frimpong, Fred Stephen Sarfo et al. · Emerging infectious diseases · 2014 · 14 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13